Literature DB >> 29601263

Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid Epidemic.

T Jake Liang1, John W Ward1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29601263      PMCID： PMC5993680          DOI： 10.1056/NEJMp1716871

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.

Authors:  Jason Grebely; Olav Dalgard; Brian Conway; Evan B Cunningham; Philip Bruggmann; Behzad Hajarizadeh; Janaki Amin; Julie Bruneau; Margaret Hellard; Alain H Litwin; Philippa Marks; Sophie Quiene; Sharmila Siriragavan; Tanya L Applegate; Tracy Swan; Jude Byrne; Melanie Lacalamita; Adrian Dunlop; Gail V Matthews; Jeff Powis; David Shaw; Maria Christine Thurnheer; Martin Weltman; Ian Kronborg; Curtis Cooper; Jordan J Feld; Chris Fraser; John F Dillon; Phillip Read; Ed Gane; Gregory J Dore
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-01-06

2.  Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.

Authors:  Huldrych F Günthard; Michael S Saag; Constance A Benson; Carlos del Rio; Joseph J Eron; Joel E Gallant; Jennifer F Hoy; Michael J Mugavero; Paul E Sax; Melanie A Thompson; Rajesh T Gandhi; Raphael J Landovitz; Davey M Smith; Donna M Jacobsen; Paul A Volberding
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

3.  Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014.

Authors:  Jon E Zibbell; Alice K Asher; Rajiv C Patel; Ben Kupronis; Kashif Iqbal; John W Ward; Deborah Holtzman
Journal:  Am J Public Health       Date:  2017-12-21       Impact factor: 9.308

Review 4.  A systematic review of injecting-related injury and disease among people who inject drugs.

Authors:  Sarah Larney; Amy Peacock; Bradley M Mathers; Matthew Hickman; Louisa Degenhardt
Journal:  Drug Alcohol Depend       Date:  2016-12-08       Impact factor: 4.492

5.  Hepatitis C Virus Infection Among Women Giving Birth - Tennessee and United States, 2009-2014.

Authors:  Stephen W Patrick; Audrey M Bauer; Michael D Warren; Timothy F Jones; Carolyn Wester
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-05-12       Impact factor: 17.586
  5 in total
  34 in total

1.  Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City.

Authors:  Kelly Quinn; Chunki Fong; Honoria Guarino; Pedro Mateu-Gelabert
Journal:  Drug Alcohol Depend       Date:  2018-11-28       Impact factor: 4.492

2.  Hepatitis C Virus Infection in the Dallas County Jail: Implications for Screening, Prevention, and Linkage to Care.

Authors:  Caroline M Abe; Merilyne Aguwa; Michelle Zhao; Jacqueline Sullivan; Esmaeil Porsa; Ank E Nijhawan
Journal:  Public Health Rep       Date:  2019-09-17       Impact factor: 2.792

3.  Hepatic IFN-Induced Protein with Tetratricopeptide Repeats Regulation of HCV Infection.

Authors:  Yuji Ishida; Masakazu Kakuni; Bo-Ram Bang; Go Sugahara; Daryl T-Y Lau; Chise Tateno-Mukaidani; Meng Li; Michael Gale; Takeshi Saito
Journal:  J Interferon Cytokine Res       Date:  2019-03       Impact factor: 2.607

Review 4.  Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.

Authors:  Anne F Peery; Seth D Crockett; Caitlin C Murphy; Jennifer L Lund; Evan S Dellon; J Lucas Williams; Elizabeth T Jensen; Nicholas J Shaheen; Alfred S Barritt; Sarah R Lieber; Bharati Kochar; Edward L Barnes; Y Claire Fan; Virginia Pate; Joseph Galanko; Todd H Baron; Robert S Sandler
Journal:  Gastroenterology       Date:  2018-10-10       Impact factor: 22.682

5.  Interrogation of Antigen Display on Individual Vaccine Nanoparticles for Achieving Neutralizing Antibody Responses against Hepatitis C Virus.

Authors:  Joseph D Bazzill; Lukasz J Ochyl; Erick Giang; Shaun Castillo; Mansun Law; James J Moon
Journal:  Nano Lett       Date:  2018-11-21       Impact factor: 11.189

6.  Evolving trends in the prevalence of hepatitis C virus antibody positivity among HIV-infected men in a community-based primary care setting.

Authors:  Yun-Chi Chen; Chloe L Thio; Farin Kamangar; Andrea L Cox; Kjell J Wiberg
Journal:  J Viral Hepat       Date:  2020-08-02       Impact factor: 3.728

7.  Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States.

Authors:  Czarina N Behrends; Ann V Nugent; Don C Des Jarlais; Jemima A Frimpong; David C Perlman; Bruce R Schackman
Journal:  J Acquir Immune Defic Syndr       Date:  2018-10-01       Impact factor: 3.731

8.  Increasing Viral Hepatitis Knowledge Among Urban Ethnic Minority Youth: Findings from a Community Based Prevention Intervention.

Authors:  Ijeoma Opara; David T Lardier; Andriana Herrera; Pauline Garcia-Reid; Robert J Reid
Journal:  J Community Health       Date:  2020-04

9.  A correlation analysis of the serum hepcidin concentrations and viral loads in HCV-infected patients.

Authors:  Rongqi Wang; Suxian Zhao; Jinghua Du; Jie Qiao; Wencong Li; Yuemin Nan
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 10.  National Public Health Burden Estimates of Endocarditis and Skin and Soft-Tissue Infections Related to Injection Drug Use: A Review.

Authors:  Isaac See; Runa H Gokhale; Andrew Geller; Maribeth Lovegrove; Asher Schranz; Aaron Fleischauer; Natalie McCarthy; James Baggs; Anthony Fiore
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.